brodalumab,guselkumab,ustekinumab
astrazeneca,leo pharma,janssen
['rheumatoid,arthritis', 'g plus', 'cobra']
our data presented at #eular2023 by lotte van ouwerkerk: is gc use over time affected by initial gc briding? an individual patient data meta-analysis based on data from best, cobra and carera. 